Compliance and Enforcement
In this section you will find information on public involvement and consultation related to compliance and enforcement activities.
Compliance and enforcement activities are a key element of safeguarding the drugs and health products to which Canadians have access.
Current consultations
- Consultation on the Risk classification guide of observations related to clinical trial inspections of human drugs (GUI-0043) [2021-11-15 - 2021-12-14]
- Notice to stakeholders – Release of draft guidance document for consultation: Annex 3A to the Good Manufacturing Practices Guide [2020-10-07]
- Notice to stakeholders – Draft guidance document for consultation: Guide to Good Manufacturing Practice for Medicinal Products Annex 1: Manufacturing of sterile medicinal products [2020-02-20]
- Notice to stakeholders – Release of draft guidance document for consultation: Annex 4 to the Good manufacturing practices guide – Veterinary drugs [2020-02-19]
- Notice to Stakeholders - Release of Good Manufacturing Practices for Active Pharmaceutical Ingredients (GUI-0104) for Consultation [2018-12-31]
- Drug and natural health products recall guide consultation [2018-11-15]
- Consultation on the List of Atypical Active Pharmaceutical Ingredients for Veterinary Use [2018-07-25]
Past Consultations
- Notice to stakeholders – Release of draft guidance document for consultation: Guidelines for environmental control of drugs during storage and transportation (GUI-0069) [2018-12-20]
- Notice to stakeholders – Release of draft guidance documents for consultation: Cleaning validation guide (GUI-0028) and Guide to validating drug dosage forms (GUI-0029) [2018-11-20]
- Consultation and Notice to Stakeholders: Release of Guidance Documents for Consultation: Various good manufacturing practices and drug establishment licensing guidance documents [2017-01-18]
- Notice to Stakeholders - Implementation of Establishment Licensing Requirements for Atypical Active Pharmaceutical Ingredients [2016-12-02]
- Consultation on the Atypical Active Pharmaceutical Ingredients List [2016-12-02]
- Regulations Amending the Food and Drug Regulations (1475 - Good Manufacturing Practices)
- Consultation: Cleaning Validation Guidance (GUI-0028) [2011-12-16]